CAPR Insider Trading
Insider Ownership Percentage: 12.00%
Insider Buying (Last 12 Months): $14,999,997.52
Insider Selling (Last 12 Months): $0.00
Capricor Therapeutics Share Price & Price History
Current Price: $14.23
Price Change: ▼ Price Decrease of -0.04 (-0.28%)
As of 01/28/2025 05:00 PM ET
Capricor Therapeutics Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
9/20/2024 | Shinyaku Co Ltd Nippon | Major Shareholder | Buy | 2,798,507 | $5.36 | $14,999,997.52 | 7,090,351 | |
10/12/2023 | David B Musket | Director | Buy | 410 | $2.75 | $1,127.50 | 31,536 | |
10/9/2023 | David B Musket | Director | Buy | 5,083 | $2.82 | $14,334.06 | 31,126 | |
10/6/2023 | Paul Gisbert Auwaerter | Director | Buy | 5,000 | $2.84 | $14,200.00 | 5,000 | |
10/4/2023 | David B Musket | Director | Buy | 2,500 | $2.90 | $7,250.00 | 26,043 | |
3/28/2023 | Xavier Avat | insider | Sell | 3,000 | $4.06 | $12,180.00 | 14,772 | |
7/6/2022 | Xavier Avat | Insider | Buy | 1,000 | $3.68 | $3,680.00 | 3,000 | |
6/29/2022 | David B Musket | Director | Sell | 28,215 | $3.77 | $106,370.55 | 12,747 | |
6/29/2022 | Xavier Avat | Insider | Buy | 1,500 | $3.76 | $5,640.00 | 2,000 | |
6/27/2022 | David B Musket | Director | Sell | 17,775 | $4.44 | $78,921.00 | 40,962 | |
Capricor Therapeutics Institutional Trading History
Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
---|
1/17/2025 | SG Americas Securities LLC | 15,317 | $0.21M | 0.0% | +74.8% | 0.034% | |
1/17/2025 | Magnus Financial Group LLC | 20,000 | $0.28M | 0.0% | N/A | 0.044% | |
1/15/2025 | Krilogy Financial LLC | 20,800 | $0.29M | 0.0% | N/A | 0.046% | |
12/26/2024 | JPMorgan Chase & Co. | 56,199 | $0.86M | 0.0% | +419.5% | 0.124% | |
11/20/2024 | Virtu Financial LLC | 30,112 | $0.46M | 0.0% | N/A | 0.066% | |
11/19/2024 | Barclays PLC | 36,296 | $0.55M | 0.0% | +106.6% | 0.080% | |
11/16/2024 | Geode Capital Management LLC | 638,189 | $9.71M | 0.0% | -0.5% | 1.405% | |
11/15/2024 | Barclays PLC | 36,296 | $0.55M | 0.0% | +106.6% | 0.080% | |
11/15/2024 | Sphera Funds Management LTD. | 61,698 | $0.94M | 0.1% | N/A | 0.136% | |
11/15/2024 | State Street Corp | 512,313 | $7.79M | 0.0% | +27.8% | 1.128% | |
11/15/2024 | Sassicaia Capital Advisers LLC | 12,600 | $0.19M | 0.6% | N/A | 0.028% | |
11/15/2024 | Point72 Asset Management L.P. | 250,204 | $3.81M | 0.0% | N/A | 0.551% | |
11/14/2024 | PFM Health Sciences LP | 152,779 | $2.32M | 0.1% | N/A | 0.336% | |
11/14/2024 | Fred Alger Management LLC | 26,241 | $0.40M | 0.0% | N/A | 0.058% | |
11/13/2024 | BNP Paribas Financial Markets | 17,699 | $0.27M | 0.0% | +868.7% | 0.039% | |
11/13/2024 | FMR LLC | 24,344 | $0.37M | 0.0% | N/A | 0.054% | |
11/13/2024 | The Manufacturers Life Insurance Company | 10,558 | $0.16M | 0.0% | N/A | 0.023% | |
11/12/2024 | Activest Wealth Management | 5,000 | $76K | 0.0% | -50.0% | 0.011% | |
11/6/2024 | Main Street Financial Solutions LLC | 22,650 | $0.35M | 0.0% | -17.6% | 0.050% | |
11/6/2024 | Oppenheimer & Co. Inc. | 68,408 | $1.04M | 0.0% | +25.2% | 0.151% | |
10/3/2024 | SG Americas Securities LLC | 8,765 | $0.13M | 0.0% | N/A | 0.027% | |
8/14/2024 | Marshall Wace LLP | 89,314 | $0.43M | 0.0% | N/A | 0.279% | |
8/9/2024 | Renaissance Technologies LLC | 137,500 | $0.66M | 0.0% | +158.7% | 0.430% | |
8/8/2024 | Main Street Financial Solutions LLC | 27,500 | $0.13M | 0.0% | +37.5% | 0.086% | |
8/1/2024 | Rhumbline Advisers | 30,886 | $0.15M | 0.0% | N/A | 0.097% | |
7/26/2024 | Bank of New York Mellon Corp | 79,782 | $0.38M | 0.0% | +12.8% | 0.249% | |
5/10/2024 | Vanguard Group Inc. | 1,365,903 | $9.27M | 0.0% | +17.2% | 4.336% | |
5/1/2024 | BNP Paribas Financial Markets | 5,827 | $40K | 0.0% | N/A | 0.018% | |
2/7/2024 | Jump Financial LLC | 52,800 | $0.26M | 0.0% | N/A | 0.171% | |
12/6/2023 | Citigroup Inc. | 61,591 | $0.21M | 0.0% | N/A | 0.200% | |
7/31/2023 | LPL Financial LLC | 78,436 | $0.38M | 0.0% | N/A | 0.310% | |
5/1/2023 | Virtu Financial LLC | 16,895 | $71K | 0.0% | N/A | 0.067% | |
11/7/2022 | Jump Financial LLC | 22,600 | $0.14M | 0.0% | N/A | 0.093% | |
10/18/2022 | Bailard Inc. | 33,601 | $0.20M | 0.0% | +12.8% | 0.138% | |
7/27/2022 | Bailard Inc. | 29,801 | $0.10M | 0.0% | N/A | 0.123% | |
4/20/2022 | Selective Wealth Management Inc. | 213,494 | $0.73M | 0.3% | N/A | 0.878% | |
11/16/2021 | Two Sigma Securities LLC | 11,511 | $46K | 0.0% | N/A | 0.050% | |
11/15/2021 | GSA Capital Partners LLP | 96,632 | $0.39M | 0.0% | -14.0% | 0.420% | |
11/15/2021 | HighTower Advisors LLC | 53,960 | $0.22M | 0.0% | +206.6% | 0.234% | |
11/9/2021 | Barclays PLC | 6,330 | $25K | 0.0% | +246.1% | 0.027% | |
11/9/2021 | BlackRock Inc. | 300,201 | $1.21M | 0.0% | -1.6% | 1.304% | |
8/17/2021 | Oracle Investment Management Inc. | 1,166,249 | $5.98M | 0.8% | -41.7% | 5.098% | |
8/16/2021 | State Street Corp | 71,748 | $0.37M | 0.0% | N/A | 0.314% | |
8/13/2021 | Northern Trust Corp | 104,251 | $0.54M | 0.0% | +7.5% | 0.456% | |
8/13/2021 | Geode Capital Management LLC | 184,990 | $0.95M | 0.0% | +7.9% | 0.809% | |
8/13/2021 | Vanguard Group Inc. | 923,233 | $4.74M | 0.0% | +1.2% | 4.035% | |
8/11/2021 | Susquehanna Fundamental Investments LLC | 16,500 | $85K | 0.0% | -49.1% | 0.072% | |
8/5/2021 | GSA Capital Partners LLP | 112,364 | $0.58M | 0.1% | +684.6% | 0.491% | |
5/18/2021 | Millennium Management LLC | 22,390 | $0.11M | 0.0% | -54.6% | 0.098% | |
5/18/2021 | Oracle Investment Management Inc. | 1,999,464 | $9.36M | 1.4% | N/A | 8.770% | |
5/12/2021 | Northern Trust Corp | 96,941 | $0.45M | 0.0% | -29.1% | 0.425% | |
5/12/2021 | M Holdings Securities Inc. | 20,000 | $94K | 0.0% | N/A | 0.088% | |
5/12/2021 | Geode Capital Management LLC | 171,415 | $0.80M | 0.0% | +40.7% | 0.752% | |
5/10/2021 | HighTower Advisors LLC | 12,300 | $57K | 0.0% | -25.9% | 0.054% | |
5/10/2021 | GSA Capital Partners LLP | 14,321 | $67K | 0.0% | -81.9% | 0.063% | |
5/7/2021 | BlackRock Inc. | 347,103 | $1.62M | 0.0% | +1.2% | 1.523% | |
5/3/2021 | Trellus Management Company LLC | 270,000 | $1.26M | 0.7% | N/A | 1.184% | |
2/11/2021 | Northern Trust Corp | 136,814 | $0.47M | 0.0% | -9.6% | 0.669% | |
2/9/2021 | Bank of New York Mellon Corp | 89,249 | $0.31M | 0.0% | +47.7% | 0.436% | |
2/5/2021 | BlackRock Inc. | 343,011 | $1.18M | 0.0% | +0.4% | 1.677% | |
2/4/2021 | GSA Capital Partners LLP | 79,091 | $0.27M | 0.0% | N/A | 0.387% | |
Data available starting January 2016
Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.
Read More on Capricor Therapeutics
Today's Range
Now: $14.23
52 Week Range
Now: $14.23
Volume
654,770 shs
Average Volume
836,128 shs
Market Capitalization
$647.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
4.08
Who are the company insiders with the largest holdings of Capricor Therapeutics?
Who are the major institutional investors of Capricor Therapeutics?
Which major investors are buying Capricor Therapeutics stock?
Within the last quarter, CAPR stock was purchased by institutional investors including:
- Krilogy Financial LLC
- Magnus Financial Group LLC
- SG Americas Securities LLC
In the previous year, these company insiders have bought Capricor Therapeutics stock:
- Shinyaku Co Ltd Nippon (Major Shareholder)
- David B Musket (Director)
- Xavier Avat (Insider)
Learn More investors buying Capricor Therapeutics stock.